AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 30621717
Drug: Indacaterol/glycopyrronium 110/50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indacaterol/glycopyrronium 110/50 μg once daily (IND/GLY)
Trial: 30621717
Drug: Salmeterol/fluticasone 50/500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol/fluticasone 50/500 twice daily (SFC)
Trial: 27861991
Drug: Evolocumab (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evolocumab (various doses from 7-420 mg SC)
Trial: 25651476
Drug: Ibogaine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibogaine (20 mg) with paroxetine pretreatment
Trial: 24335445
Drug: AZD9773 low
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: AZD9773 low dose (250 U/kg followed by 50 U/kg every 12 hours)
Trial: 24335445
Drug: AZD9773 high
RxNorm normalized name: HIGH DENSITY POLYETHYLENE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD9773 high dose (500 U/kg followed by 100 U/kg every 12 hours)
Trial: 22659487
Drug: Tiotropium (18
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium (18 μg od)
Trial: 11955393
Drug: Single 80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single 80 mg epirubicin
Trial: 11955393
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg consecutive epirubicin
Trial: 11955393
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg consecutive mitomycin C
Trial: 6750929
Drug: Alpha- and
RxNorm normalized name: Alpha- and beta-trypsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpha- and betamimetics, cholinesterase inhibitors
Trial: 30732459
Drug: Program A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Program A (two months without acute analgesics or migraine medications)
Trial: 30732459
Drug: Program B
RxNorm normalized name: ZINC OXIDE 3 g in 100 g / OCTOCRYLENE 6 g in 100 g / ENSULIZOLE 4 g in 100 g / TITANIUM DIOXIDE 2.4 g in 100 g TOPICAL CREAM [NECK DECOLLETE HAND ARM DAY REPARATIVE HYDRATION RESCUE AND REPROGRAM BROAD SPECTRUM SPF 35 SUNSCREEN]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Program B (two months with acute medications restricted to two days/week)
Trial: 21627398
Drug: Standard triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard triple drug therapy (omeprazole, clarithromycin, and amoxicillin for 10 days)
Trial: 15211234
Drug: Pristinamycin 3
RxNorm normalized name: pristinamycin
DrugBank: Pristinamycin (DB13704)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pristinamycin 3 G daily for 4 days
Trial: 15211234
Drug: Co-amoxiclav 2
RxNorm normalized name: CO
DrugBank: Carbon monoxide (DB11588)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-amoxiclav 2 G daily for 8 days
Trial: 11683127
Drug: Lanzor (reference
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lanzor (reference formulation)
Trial: 8701855
Drug: Flosequinan 100
RxNorm normalized name: flosequinan 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flosequinan 100 mg once daily
Trial: 8701855
Drug: Flosequinan 75
RxNorm normalized name: flosequinan 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flosequinan 75 mg twice daily
Trial: 1876437
Drug: ICS 205-930
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICS 205-930 (15 mg daily)
Trial: 1876437
Drug: ICS 205-930
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICS 205-930 (25 mg daily)
Trial: 1876437
Drug: ICS 205-930
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICS 205-930 (50 mg daily)
Trial: 22416798
Drug: darunavir/ritonavir plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: darunavir/ritonavir plus nucleoside reverse transcriptase inhibitors (triple therapy)
Trial: 4006483
Drug: Beta-Blocker Heart
RxNorm normalized name: porcine heart preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-Blocker Heart Attack Trial (BHAT)
Trial: 28980306
Drug: 50% oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50% oxygen inhalation
Trial: 16962720
Drug: Air inhalation
RxNorm normalized name: air
DrugBank: Medical air (DB09337)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Air inhalation
Trial: 25500684
Drug: Intravenous sodium
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous sodium valproate
Trial: 27878767
Drug: Intravenous phenobarbital
RxNorm normalized name: Phenobarbital
DrugBank: Phenobarbital (DB01174)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous phenobarbital
Trial: 19473858
Drug: articaine 20mg/ml
FDA approved: no
EMA approved: no
PMDA approved: no
Description: articaine 20mg/ml
Trial: 19473858
Drug: articaine 40mg/ml
FDA approved: no
EMA approved: no
PMDA approved: no
Description: articaine 40mg/ml
Trial: 11898704
Drug: Vaginal solution
RxNorm normalized name: VAGINAL SOLUTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal solution 40 mg of phentolamine
Trial: 11898704
Drug: Oral tablet
RxNorm normalized name: Oral Tablet
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral tablet 40 mg of phentolamine
Trial: 9895068
Drug: Sympathectomy (lidocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sympathectomy (lidocaine injection into the brachial plexus)
Trial: 9895068
Drug: Isotonic sodium
RxNorm normalized name: ISOTONIC SODIUM CHLORIDE SOLUTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotonic sodium chloride solution injection (placebo)
Trial: 7297411
Drug: Naltrexone (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone (50 or 100 mg)
Trial: 16162624
Drug: No ACE
RxNorm normalized name: Amino Acetic Acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No ACE inhibitors
Trial: 11044647
Drug: Method of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Method of treatment allocation
Trial: 8471439
Drug: Cooper type
RxNorm normalized name: collagen type I
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cooper type regimens without doxorubicin (replaced by one or more compounds)
Trial: 26669628
Drug: Ospemifene 60
RxNorm normalized name: ospemifene 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ospemifene 60 mg/day
Trial: 29105211
Drug: Parent-focused family-based
RxNorm normalized name: C.I. direct red 28 parent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parent-focused family-based treatment (PFT)
Trial: 20568829
Drug: Sugammadex 4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sugammadex 4 mg/kg alone
Trial: 20568829
Drug: Sugammadex 32
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sugammadex 32 mg/kg with rocuronium 1.2 mg/kg
Trial: 20568829
Drug: Sugammadex 32
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sugammadex 32 mg/kg with vecuronium 0.1 mg/kg
Trial: 18334007
Drug: Weekly topotecan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly topotecan (4 mg/m(2))
Trial: 8282360
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg fosinopril plus 12.5 mg hydrochlorothiazide
Trial: 10856268
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg fosinopril
Trial: 3534801
Drug: 12.5 mg
RxNorm normalized name: rutin 12.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12.5 mg hydrochlorothiazide
Trial: 2567740
Drug: Ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine 150 mg bid
Trial: 31698825
Drug: Pemafibrate 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pemafibrate 0.1 mg/day
Trial: 31698825
Drug: Pemafibrate 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pemafibrate 0.2 mg/day
Trial: 21901116
Drug: HealthyDiet group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HealthyDiet group (whole grain and low postprandial insulin response grain products, fatty fish three times a week, and bilberries three portions per day)
Trial: 12611748
Drug: HL 2
RxNorm normalized name: SODIUM CHLORIDE 0.9% INHL 2.5ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HL 2 mg-3 mg/day (standard dose)
Trial: 11317829
Drug: Oral gatifloxacin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral gatifloxacin 400 mg once daily
Trial: 9174486
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g n-3 ethyl esters three times a day for 2 months
Trial: 9174486
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g n-3 ethyl esters twice a day for 4 months
Trial: 21169815
Drug: Atorvastatin (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (80 mg 12 hours before PCI, plus 40 mg preprocedure)
Trial: 16910475
Drug: Sevoflurane with
RxNorm normalized name: Sevoflurane
DrugBank: Sevoflurane (DB01236)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sevoflurane with 0.6 mg x kg(‐1) Org 9426
Trial: 16910475
Drug: Propofol with
RxNorm normalized name: propofol with medium chain triglycerides 10 mg/mL intravenous emulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol with 0.6 mg x kg(‐1) Org 9426
Trial: 16910475
Drug: Sevoflurane with
RxNorm normalized name: Sevoflurane
DrugBank: Sevoflurane (DB01236)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sevoflurane with 0.9 mg x kg(‐1) Org 9426
Trial: 16910475
Drug: Propofol with
RxNorm normalized name: propofol with medium chain triglycerides 10 mg/mL intravenous emulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol with 0.9 mg x kg(‐1) Org 9426
Trial: 16910475
Drug: Sevoflurane (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sevoflurane (both doses)
Trial: 16910475
Drug: Propofol (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (both doses)
Trial: 16910475
Drug: 0.9 mg
RxNorm normalized name: estradiol 0.9 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9 mg x kg(‐1) Org 9426
Trial: 15479777
Drug: High-dose (>30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose (>30 mg/kg) rectally administered acetaminophen
Trial: 9134651
Drug: PAI-1 activity
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PAI-1 activity in stroke patients (n = 245) at presentation (11.6 U/ml) and after three months (11.8 U/ml)
Trial: 31400231
Drug: 0.2 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 g/kg IgPro20
Trial: 31400231
Drug: 0.4 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4 g/kg IgPro20
Trial: 30058061
Drug: Intramuscular 8mg
RxNorm normalized name: intramuscular immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular 8mg lornoxicam (Group 1, n=27)
Trial: 30058061
Drug: Intravenous 8mg
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous 8mg lornoxicam (Group 2, n=24)
Trial: 19398614
Drug: Immediate intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Immediate intervention consisting of eighteen 30‐minute lessons delivered twice weekly for 9 weeks, focusing on teaching critical emergent literacy skills within small groups.
Trial: 10397521
Drug: 2% minocycline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% minocycline ointment
Trial: 2426069
Drug: Preoperative chemotherapy
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative chemotherapy (COF regimen: Vincristine 1 mg, cyclophosphamide 600 mg, 5-fluorouracil 500 mg IV on days 1 and 8, with or without Pingyangmycin 10 mg IM on days 1, 3, 6, and 8)
Trial: 30673004
Drug: Home-based exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home-based exercise therapy with a single supervised session (Group A)
Trial: 23150095
Drug: Conservative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative treatment (observation)
Trial: 17443645
Drug: Oral bicalutamide
RxNorm normalized name: Bicalutamide
DrugBank: Bicalutamide (DB01128)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral bicalutamide
Trial: 15886663
Drug: Intermittent pneumatic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent pneumatic calf and foot compression (IPCFC) applied for 1 hour twice daily in the sitting position, along with daily exercise.
Trial: 12562884
Drug: Daily supervised
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily supervised brushing with fluoride toothpaste
Trial: 11084786
Drug: Adenosine (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adenosine (3 mg bolus) with K(+)-enriched cardioplegia
Trial: 10201459
Drug: Ranitidine 300
RxNorm normalized name: ranitidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 300 mg twice daily
Trial: 6628792
Drug: 2.0% DNCB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.0% DNCB ointment for 2 days followed by 0.05% DNCB ointment daily (group I)
Trial: 6628792
Drug: 0.05% DNCB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05% DNCB preparation only (group II)
Trial: 20464985
Drug: Intervention treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention treatment group (systemic patient management including patient education, regular telephone interviews, physician-patient communication)
Trial: 20464985
Drug: General treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General treatment group (normal clinical procedure)
Trial: 20464985
Drug: Intervention treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention treatment group
Trial: 17013594
Drug: Increasing contrast
RxNorm normalized name: Contrased
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increasing contrast agent dosage
Trial: 15653005
Drug: Low-dose hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Low-dose hormone replacement therapy with 0.3mg of conjugated equine estrogens (CE) and 2.5 mg MPA (CE + MPA)
Trial: 15653005
Drug: Low-dose hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Low-dose hormone replacement therapy with 0.3mg of conjugated equine estrogens (CE) and 100 mg natural micronized progesterone (CE + P)
Trial: 7542336
Drug: Sublingual buprenorphine
RxNorm normalized name: buprenorphine Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual buprenorphine (0, 0.5, 2, 8, 16 and 32 mg)
Trial: 7542336
Drug: p.o. methadone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: p.o. methadone (3.75, 15 and 60 mg)
Trial: 7542336
Drug: High doses
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High doses of methadone
Trial: 2221770
Drug: Bupivacaine (0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine (0.6 ml/kg, 0.25% = 1.5 mg/kg) injected intradermally into the wound during general anaesthesia
Trial: 1389845
Drug: Suxamethonium 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suxamethonium 1 mg kg‐1
Trial: 26111150
Drug: Ramipril (usual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramipril (usual treatment group)
Trial: 17325084
Drug: No doxycycline
RxNorm normalized name: Doxycycline
DrugBank: Doxycycline (DB00254)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No doxycycline treatment (Control)
Trial: 28581335
Drug: Daily diary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily diary writing
Trial: 8991468
Drug: Propofol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (2 mg/kg induction, 15-20 mg/kg x h maintenance with 30% O2 in air)
Trial: 8991468
Drug: Propofol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (2 mg/kg induction, 10-15 mg/kg x h maintenance with N2O)
Trial: 14551368
Drug: Bicarbonate concentration
RxNorm normalized name: Potassium Bicarbonate
DrugBank: Potassium bicarbonate (DB11098)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bicarbonate concentration 32 mmol/l (modality A)
Trial: 10843171
Drug: Risedronate 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risedronate 2.5 mg/day
Trial: 10841169
Drug: Combined risedronate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined risedronate treatment groups
Trial: 2863596
Drug: Thrombolysis (intracoronary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolysis (intracoronary streptokinase up to 250,000 U, with some receiving intravenous streptokinase 500,000 U)
Trial: 26429652
Drug: Brazil nuts
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brazil nuts (15 to 30 g, 3 days/week)
Trial: 18257349
Drug: Acupuncture plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture plus ear point tapping and pressing therapy
Trial: 7797783
Drug: Routine cleaning
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine cleaning measures including daily cleaning of smooth floors, weekly laundering of sheets, and monthly cleaning of soft toys; use of synthetic mattress covers.
Trial: 22151936
Drug: 4% hydroquinone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4% hydroquinone cream
Trial: 23649578
Drug: 0.4% Stannous
RxNorm normalized name: Stanimax 0.4% Stannous Fluoride Dental Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4% Stannous Fluoride Gel
Trial: 21735693
Drug: Metformin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin therapy (1700 mg daily for 6 months)
Trial: 20104753
Drug: Ganciclovir (GCV)
RxNorm normalized name: Ganciclovir
DrugBank: Ganciclovir (DB01004)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ganciclovir (GCV) 5-10 mg/(kg x d) for 5 days
Trial: 16916184
Drug: Inhaled anaesthetics
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled anaesthetics
Trial: 12625640
Drug: Intramuscular EMG-controlled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular EMG-controlled NMES
Trial: 8887920
Drug: argon laser
RxNorm normalized name: argon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: argon laser treatment (ALT)
Trial: 8887920
Drug: double-frequency Nd:YAG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: double-frequency Nd:YAG laser treatment (NdLT)
Trial: 3517643
Drug: Penicillamine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Penicillamine (10 mg/kg/day)
Trial: 3517643
Drug: Hydroxychloroquine (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxychloroquine (6 mg/kg/day)
Trial: 25440796
Drug: Alirocumab (75-150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alirocumab (75-150 mg biweekly injections)
Trial: 29604186
Drug: Placebo (matching
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (matching injections)
Trial: 22753208
Drug: Antihypertensive agents
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypertensive agents for approximately 12 months
Trial: 18310581
Drug: Cognitive-behavioural therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioural therapy plus treatment as usual
Trial: 11168249
Drug: Maxillary long-bar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maxillary long-bar implant overdentures with palatal coverage
Trial: 31888944
Drug: Free and
RxNorm normalized name: Free and Clear
DrugBank: Pyrithione (DB06815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Free and easily accessible medicines (intervention)
Trial: 26254237
Drug: GP care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GP care with additional exercise therapy (maximum of 12 sessions in the first 3 months and three booster sessions thereafter)
Trial: 24462034
Drug: Standard medications
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard medications
Trial: 22730862
Drug: Timely bolus
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timely bolus insulin (0.2 iu/kg at aortic cannulation, additional 0.1 iu/kg for BG > 10.0 mmol/L)
Trial: 22730862
Drug: Timely bolus
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timely bolus insulin
Trial: 3653498
Drug: Propranolol (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (40 mg three times a day)
Trial: 9045106
Drug: Inactivated Lactobacillus
RxNorm normalized name: Lactobacillus reuteri
DrugBank: Lactobacillus reuteri (DB14224)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactivated Lactobacillus acidophilus with antibiotic therapy for extraintestinal pathologies
Trial: 6733040
Drug: Short-contact dithranol
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-contact dithranol therapy
Trial: 30879707
Drug: Weekly low-grade
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly low-grade (I-II) Kaltenborn manual mobilization of the hands
Trial: 30006117
Drug: Single-implant mandibular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-implant mandibular overdentures (SIMO)
Trial: 26828801
Drug: Paraspinous lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Paraspinous lidocaine injection, analgesics, and exercises (LID-INJ)
Trial: 26828801
Drug: Sham paraspinous
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham paraspinous lidocaine injection, analgesics, and exercises (SH-INJ)
Trial: 26828801
Drug: Analgesics and
RxNorm normalized name: Analgesics and anesthetics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Analgesics and exercises (STD-TTR)